ARROWHEAD PHARMACEUTICALS, INC. Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. for December 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Gift | G | 0.00 | 1,126 | 0 | 2,544,621 | 2.5 M to 2.5 M (-0.04 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 35 | 0 | 113,868 | 113.9 K to 113.9 K (-0.03 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 35 | 0 | 113,903 | 113.9 K to 113.9 K (-0.03 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 200 | 0 | 113,938 | 114.1 K to 113.9 K (-0.18 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 35 | 0 | 114,138 | 114.2 K to 114.1 K (-0.03 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 35 | 0 | 114,173 | 114.2 K to 114.2 K (-0.03 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 200 | 0 | 114,208 | 114.4 K to 114.2 K (-0.17 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 200 | 0 | 114,408 | 114.6 K to 114.4 K (-0.17 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 65 | 0 | 114,608 | 114.7 K to 114.6 K (-0.06 %) |
| Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 65 | 0 | 114,673 | 114.7 K to 114.7 K (-0.06 %) |
| Dec 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 6.15 | 28,274 | 173,885 | 800,033 | |
| Dec 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 4.75 | 12,236 | 58,121 | 828,307 | |
| Dec 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 6.15 | 28,274 | 173,885 | 2,545,747 | 2.5 M to 2.5 M (+1.12 %) |
| Dec 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 4.75 | 12,236 | 58,121 | 2,517,473 | 2.5 M to 2.5 M (+0.49 %) |
| Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 79.59 | 500 | 39,795 | 15,000 | 15.5 K to 15 K (-3.23 %) |
| Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 79.30 | 9,075 | 719,648 | 114,738 | 123.8 K to 114.7 K (-7.33 %) |
| Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 15,500 | 0 | 15,500 | 0 to 15.5 K |
| Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 15,500 | 0 | 15,500 | 0 to 15.5 K |
| Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 31,000 | 0 | 123,813 | 154.8 K to 123.8 K (-20.02 %) |
| Dec 11 2020 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Sell | S | 73.10 | 1,800 | 131,580 | 25,000 | 26.8 K to 25 K (-6.72 %) |
| Dec 11 2020 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Sell | S | 68.50 | 1,200 | 82,200 | 26,800 | 28 K to 26.8 K (-4.29 %) |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 2.01 | 38,676 | 77,739 | 840,543 | |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 2.01 | 16,324 | 32,811 | 879,219 | |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 71.61 | 4,003 | 286,655 | 2,505,237 | 2.5 M to 2.5 M (-0.16 %) |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 70.87 | 5,880 | 416,716 | 2,509,240 | 2.5 M to 2.5 M (-0.23 %) |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 69.80 | 12,067 | 842,277 | 2,515,120 | 2.5 M to 2.5 M (-0.48 %) |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 67.27 | 16,726 | 1,125,158 | 2,527,187 | 2.5 M to 2.5 M (-0.66 %) |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 2.01 | 38,676 | 77,739 | 2,543,913 | 2.5 M to 2.5 M (+1.54 %) |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 67.97 | 16,324 | 1,109,542 | 2,505,237 | 2.5 M to 2.5 M (-0.65 %) |
| Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 2.01 | 16,324 | 32,811 | 2,521,561 | 2.5 M to 2.5 M (+0.65 %) |